Cargando…
The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation
BACKGROUND: In the European Union, medicines are authorised for some rare disease only if they are judged to be dissimilar to authorised orphan drugs for that disease. This paper describes the use of 2D fingerprints to show the extent of the relationship between computed levels of structural similar...
Autores principales: | Franco, Pedro, Porta, Nuria, Holliday, John D, Willett, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923256/ https://www.ncbi.nlm.nih.gov/pubmed/24485002 http://dx.doi.org/10.1186/1758-2946-6-5 |
Ejemplares similares
-
The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America
por: Arnold, Renée J.G., et al.
Publicado: (2015) -
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2019) -
Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
por: Gammie, Todd, et al.
Publicado: (2015) -
Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional Analysis
por: Döring, Jan Henje, et al.
Publicado: (2016) -
Multiple search methods for similarity-based virtual screening: analysis of search overlap and precision
por: Holliday, John D, et al.
Publicado: (2011)